Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Glecaprevir + pibrentasvir (ABT493 + ABT-530) for the treatment of Hepatitis C'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science